Aviva’s Astera Labs ALAB Stock Holding History

Aviva’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.2M	Buy	103,896 +10,524	+11%	+$2.79M	0.07%	247
2026 Q1	$10.2M	Buy	93,372 +7,982	+9%	+$1.14M	0.02%	529
2025 Q4	$14.2M	Buy	85,390 +83,028	+3,515%	+$13.9M	0.02%	479
2025 Q3	$462K	Buy	+2,362	New	+$388K	﹤0.01%	811

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aviva's ALAB Position: Q2 2026 in Review

Aviva increased its Astera Labs (ALAB) stake by 11% in Q2 2026, buying an estimated $2.79M and bringing the position to 103,896 shares worth $50.2M. The position accounts for 0.07% of the portfolio, ranked #247.

Aviva first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Aviva held 103,896 shares of Astera Labs worth $50.2M as of Q2 2026.
Aviva bought 10,524 Astera Labs shares in Q2 2026, an estimated $2.79M.
Astera Labs made up 0.07% of Aviva's portfolio in Q2 2026, its #247 holding.
Aviva first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.